CARE
Price
$30.57
Change
-$0.13 (-0.42%)
Updated
Oct 23 closing price
Capitalization
708.12M
95 days until earnings call
Intraday BUY SELL Signals
GSBC
Price
$80.93
Change
+$2.00 (+2.53%)
Updated
Oct 23 closing price
Capitalization
881.94M
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CARE vs GSBC

CARE vs GSBC Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CARE vs. GSBC commentary
Oct 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARE is a Buy and GSBC is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CARE with price predictions
Oct 23, 2026

Momentum Indicator for CARE turns positive, indicating new upward trend

CARE saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator turned positive. In 53 of the 72 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CARE just turned positive on October 02, 2026. Looking at past instances where CARE's MACD turned positive, the stock continued to rise in 26 of 37 cases over the following month. The odds of a continued upward trend are 70%.

Following a +1.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where CARE advanced for three days, in 211 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

CARE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CARE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.

The Aroon Indicator for CARE entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron SMR rating for this company is 23 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CARE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.313) is normal, around the industry mean (1.271). P/E Ratio (5.271) is within average values for comparable stocks, (13.247). Projected Growth (PEG Ratio) (0.130) is also within normal values, averaging (1.190). Dividend Yield (0.013) settles around the average of (0.035) among similar stocks. P/S Ratio (3.140) is also within normal values, averaging (3.738).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for GSBC with price predictions
Oct 23, 2026

GSBC in upward trend: price rose above 50-day moving average on October 22, 2026

GSBC moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on GSBC as a result. In 54 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.

The Moving Average Convergence Divergence (MACD) for GSBC just turned positive on October 20, 2026. Looking at past instances where GSBC's MACD turned positive, the stock continued to rise in 27 of 53 cases over the following month. The odds of a continued upward trend are 51%.

Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where GSBC advanced for three days, in 148 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for GSBC crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GSBC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

GSBC broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GSBC entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. GSBC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.375) is normal, around the industry mean (1.271). P/E Ratio (13.333) is within average values for comparable stocks, (13.247). Projected Growth (PEG Ratio) (1.070) is also within normal values, averaging (1.190). Dividend Yield (0.021) settles around the average of (0.035) among similar stocks. P/S Ratio (3.922) is also within normal values, averaging (3.738).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

FUNDAMENTALS RATINGS
CARE vs GSBC: Fundamental Ratings
CARE
GSBC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
2018
SMR RATING
1..100
2329
PRICE GROWTH RATING
1..100
4141
P/E GROWTH RATING
1..100
9312
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CARE's Valuation (47) in the Regional Banks industry is in the same range as GSBC (74) in the Savings Banks industry. This means that CARE’s stock grew similarly to GSBC’s over the last 12 months.

GSBC's Profit vs Risk Rating (18) in the Savings Banks industry is in the same range as CARE (20) in the Regional Banks industry. This means that GSBC’s stock grew similarly to CARE’s over the last 12 months.

CARE's SMR Rating (23) in the Regional Banks industry is in the same range as GSBC (29) in the Savings Banks industry. This means that CARE’s stock grew similarly to GSBC’s over the last 12 months.

CARE's Price Growth Rating (41) in the Regional Banks industry is in the same range as GSBC (41) in the Savings Banks industry. This means that CARE’s stock grew similarly to GSBC’s over the last 12 months.

GSBC's P/E Growth Rating (12) in the Savings Banks industry is significantly better than the same rating for CARE (93) in the Regional Banks industry. This means that GSBC’s stock grew significantly faster than CARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAREGSBC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 2 days ago
53%
Declines
ODDS (%)
Bearish Trend 6 days ago
61%
Bearish Trend 11 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
69%
COMPARISON
Comparison
Oct 25, 2026
Stock price -- (CARE: $30.57 vs. GSBC: $80.93)
Brand notoriety: CARE and GSBC are both not notable
Both companies represent the Regional Banks industry
Current volume relative to the 65-day Moving Average: CARE: 72% vs. GSBC: 105%
Market capitalization -- CARE: $708.12M vs. GSBC: $881.94M
CARE [@Regional Banks] is valued at $708.12M. GSBC’s [@Regional Banks] market capitalization is $881.94M. The market cap for tickers in the [@Regional Banks] industry ranges from $147.99 to $173.74B. The average market capitalization across the [@Regional Banks] industry is $6.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARE’s FA Score shows that 2 FA rating(s) are green while GSBC’s FA Score has 3 green FA rating(s).

  • CARE’s FA Score: 2 green, 3 red.
  • GSBC’s FA Score: 3 green, 2 red.
According to our system of comparison, both CARE and GSBC are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARE’s TA Score shows that 4 TA indicator(s) are bullish while GSBC’s TA Score has 4 bullish TA indicator(s).

  • CARE’s TA Score: 4 bullish, 3 bearish.
  • GSBC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CARE is a better buy in the short-term than GSBC.

Price Growth

CARE (@Regional Banks) experienced а +1.19% price change this week, while GSBC (@Regional Banks) price change was +3.69% for the same time period.

The average weekly price growth across all stocks in the @Regional Banks industry was +2.29%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was +9.12%.

Reported Earning Dates

CARE is expected to report earnings on Jan 28, 2027.

GSBC is expected to report earnings on Jan 25, 2027.

Industries' Descriptions

@Regional Banks (+2.29% weekly)

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

View a ticker or compare two or three
CARE
Daily Signal:
Gain/Loss:
GSBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BANC17.920.18
+1.01%
Banc of California
CARS10.940.03
+0.27%
Cars.com
ULBI6.07-0.11
-1.78%
Ultralife Corp
TRU81.48-1.98
-2.37%
TransUnion
CRE2.48-0.07
-2.75%
Cre8 Enterprise Ltd